A0A0S2Z3Y8 (A0A0S2Z3Y8_HUMAN) Homo sapiens (Human)
Tyrosine-protein kinase UniProtKBInterProInteractive Modelling
509 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: P06239; Pan troglodytes: A0A2J8IYW7; Pan paniscus: A0A2R9AKH9; Gorilla gorilla gorilla: G3QJD4
It is possible new templates exist for this target since these models were created.
Available Structures
57 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| SH3-SH2 DOMAIN FRAGMENT OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 10 RESIDUE SYNTHETIC PH… |
Heteromer P06239; | 100 | ||||
| Crystal Structure of Lck SH2-SH3 with SH2 binding site of p130Cas |
Heteromer P06239; Q63767; | 100 | 6×NA; | |||
| Monobody Mb(Lck_3) bound to Lck-SH2 domain |
Heteromer P06239; | 100 | 2×ZN; | |||
| SH2 (SRC HOMOLOGY-2) DOMAIN OF HUMAN P56-LCK TYROSINE KINASE COMPLEXED WITH THE 11 RESIDUE PHOSPHOT… |
Heteromer P03079; P06239; | 100 | ||||
| FREE P56LCK SH2 DOMAIN |
Heteromer P06239; | 100 | ||||
| Monobody Mb(Lck_1) bound to Lck-Sh2 |
Heteromer P06239; | 100.0 | 3×SO4; | |||
| Solution structure of T-cell surface glycoprotein CD8 alpha chain and Proto-oncogene tyrosine-prote… |
Heteromer P01732; P06239; | 96.55 | 1×ZN; | |||
| Solution structure of T-cell surface glycoprotein CD4 and Proto-oncogene tyrosine-protein kinase LC… |
Heteromer P01730; P06239; | 96.55 | 1×ZN; | |||
| Protein Tyrosine Phosphatase PTPN-22 (Lyp) bound to the mono-Phosphorylated Lck active site peptide |
Heteromer P06239; Q9Y2R2; | 100 | 1×PO4; | |||
| Crystal structure of UNC119 in complex with LCK peptide |
Heteromer P06239; Q13432; | 100 | 2×GOL; 1×15P; 1×MYR; | |||
| crystal structure of aminoquinazoline 1 bound to Lck | homo-2-mer | 100.0 | 2×242; | |||
| HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE | homo-2-mer | 100 | ||||
| SH3 Domain of Human Lck | homo-2-mer | 100 | 2×ZN; 2×CA; 2×PG4; | |||
| Tyrosine-protein kinase LCK bound to Compound 11 | monomer | 100.0 | 1×ODJ; 1×CXS; 2×SO4; 1×NI; | |||
| Crystal structure of Triazolone derivative bound to the kinase domain of human LCK, (auto-phosphory… | monomer | 100 | 2×SO4; 1×DMS; 1×MPD; 1×5PB; | |||
| x-ray crystal structure of 2-aminopyrimidine carbamate 43 bound to Lck | monomer | 100 | 1×SO4; 1×1N9; | |||
| Crystal structure of Pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 100 | 2×SO4; 1×DMS; 1×KSC; | |||
| STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM… | monomer | 100 | 3×SO4; 1×ANP; 1×EDO; | |||
| Crystal structure of pyrazin derivative bound to the kinase domain of Human LCK, (Auto-phosphorylat… | monomer | 100 | 2×SO4; 1×DMS; 1×MPD; 1×KZI; | |||
| X-ray co-crystal structure aminobenzimidazole triazine 1 bound to Lck | monomer | 100 | 2×SO4; 1×AM0; | |||
| STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM… | monomer | 98.9 | 1×SO4; 1×STU; | |||
| Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 100 | 2×SO4; 1×DMS; 1×MPD; 1×KSE; | |||
| Crystal Structure of Methoxy Benzofuran Derivative bound to the Kinase domain of human LCK, (auto-p… | monomer | 100 | 2×SO4; 1×DMS; 1×MPD; 1×KBM; | |||
| Crystal structure of imidazo pyrimidine derivative bound to the kinase domain of human LCK, (Auto-p… | monomer | 100 | 2×SO4; 1×DMS; 1×KSS; | |||
| co-crystal structure of Lck and aminopyrimidine amide 10b | monomer | 100.0 | 1×AM5; | |||
| Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 100 | 2×SO4; 1×DMS; 1×KZM; | |||
| Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 100 | 2×SO4; 1×KSH; | |||
| Crystal structure of Pyrrolo pyrazine derivative bound to the kinase domain of human LCK, (auto-pho… | monomer | 100 | 2×SO4; 1×DMS; 1×KSR; | |||
| Crystal structure of triazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 100 | 2×SO4; 1×DMS; 1×KZL; | |||
| THE KINASE DOMAIN OF HUMAN LYMPHOCYTE KINASE (LCK), ACTIVATED FORM (AUTO-PHOSPHORYLATED ON TYR394) | monomer | 100 | 1×SO4; | |||
| STRUCTURAL ANALYSIS OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH NON-SELECTIVE AND SRC FAM… | monomer | 100 | 3×SO4; 1×PP2; | |||
| X-Ray co-crystal structure of 2-amino-6-phenylpyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-… | monomer | 100 | 1×SO4; 1×AM9; | |||
| crystal structure of furanopyrimidine 8 bound to lck | monomer | 100 | 1×547; | |||
| Crystal structure of imidazo pyrazin 1 bound to the kinase domain of human LCK, (auto-phosphorylate… | monomer | 100 | 2×SO4; 1×DMS; 1×KSF; | |||
| Crystal structure of pyrazolo pyrimidine derivative bound to the kinase domain of human LCK, (auto-… | monomer | 100 | 2×SO4; 1×KSK; | |||
| co-crystal structure of Lck and aminopyrimidine reverse amide 23 | monomer | 100.0 | 1×AM6; | |||
| Crystal structure of phenylimidazo pyrazin 2 bound to the kinase domain of human LCK, (auto-phospho… | monomer | 100 | 1×SO4; 1×KSL; | |||
| crystal structure of furanopyrimidine 1 bound to lck | monomer | 100 | 1×979; | |||
| Crystal structure of imidazo quinoxaline 1 bound to the kinase domain of human LCK, activated form … | monomer | 100 | 2×SO4; 1×DMS; 1×KSM; | |||
| Structure of human LCK kinase with a small molecule inhibitor | monomer | 100 | 1×LHL; 1×SO4; | |||
| LCK bound to imatinib | monomer | 100 | 1×STI; | |||
| CRYSTAL STRUCTURE OF THE LYMPHOCYTE-SPECIFIC KINASE LCK IN COMPLEX WITH STAUROSPORINE. | monomer | 100 | 1×SO4; 1×STU; | |||
| The complex crystal structure of LCK with a probe molecule w259 | monomer | 100 | 1×SO4; 1×CA; 1×925; | |||
| crystal structure of aminoquinazoline 36 bound to Lck | monomer | 100.0 | 1×1N8; | |||
| Crystal structure of pyrimidine amide 11 bound to Lck | monomer | 100.0 | 1×9NH; | |||
| Structure of Lck in complex with a compound discovered by Virtual Fragment Linking | monomer | 99.61 | 1×7KW; | |||
| LCK complexed with a pyrazolopyrimidine | monomer | 99.61 | 1×5LK; 1×EDO; | |||
| Crystal structure of a SH3-SH2 domains of a lymphocyte-specific protein tyrosine kinase (LCK) from … | monomer | 100 | 1×SO4; 2×GOL; | |||
| HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU… | monomer | 100 | 1×ACE; | |||
| P56LCK SH2 DOMAIN INHIBITOR COMPLEX | monomer | 100 | ||||
| HUMAN P56-LCK TYROSINE KINASE SH2 DOMAIN IN COMPLEX WITH THE PHOSPHOTYROSYL PEPTIDE AC-PTYR-GLU-GLU… | monomer | 100 | ||||
| Crystal structure of LCK SH2 complexed with nonpeptide phosphotyrosine mimetic | monomer | 98.08 | 1×CC0; | |||
| Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo … | monomer | 99.04 | 1×CC1; | |||
| The Crystal Structure of LCK from Biortus. | monomer | 100.0 | 1×CL; 1×EDO; 1×PG4; | |||
| HUMAN P56LCK TYROSINE KINASE COMPLEXED WITH PHOSPHOPEPTIDE | monomer | 100 | ||||
| SH3 domain of human Lck tyrosine kinase | monomer | 98.41 | ||||
| SH3 Domain of Lymphocyte Specific Kinase (LCK) | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 9byj.1.A | monomer | 0.79 | 72.13 | |||
| 1y57.1.A | monomer | 0.78 | 60.59 | |||
| 1opl.2.A | monomer | 0.75 | 43.06 | |||
| 8gmb.1.A | monomer | 0.71 | 35.85 | |||